Nataša Levičar

1.4k citations
15 papers · 618 indexed · h-index 11

Impact in

Papers in

Nataša Levičar

14 papers receiving 595 citations

Peers

Nataša Levičar
Comparison fields: 5 of 81
  • Cancer Research 191
  • Hepatology 91
  • Genetics 115
  • Immunology and Allergy 63
  • Molecular Biology 302
Replace Stefan Grotegut with:
Stefan Grotegut United States
Simone Merlin Italy
Rifat Hasina United States
A Anjo France
Nadia Coltella Italy
T Tsukada Japan
D. Fan United States
Luciana L. Almada United States
Carolyn V. Ustach United States
Michelle Burrows United States
Nataša Levičar relative to Stefan Grotegut United States Stefan Grotegut's profile →
Citations per field
00.5×4.3×
Stefan Grotegut · 1×
Citations per year

Countries citing papers authored by Nataša Levičar

Since Specialization
Citations

This map shows the geographic impact of Nataša Levičar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nataša Levičar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nataša Levičar more than expected).

Fields of papers citing papers by Nataša Levičar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nataša Levičar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nataša Levičar. The network helps show where Nataša Levičar may publish in the future.

Co-authors

The 25 scholars most cited alongside Nataša Levičar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nataša Levičar Line = papers co-authored together Nataša Levičar links everyone, so they are left out of the graph.

All Works

15 of 15 papers shown
#Work
1 201216
2 20112
3 200836
4 200858
5 200715
6 200797
7 20070
8 20069
9 20065
10 200510
11 2003131
12 200391
13 200273
14 200247
15 200028

About Nataša Levičar

Nataša Levičar is a scholar working on Genetics, Cancer Research, Hepatology, Developmental Neuroscience and Molecular Biology, having authored 15 papers that have together received 618 indexed citations. Recurring topics across this work include Pluripotent Stem Cells Research (5 papers), Protease and Inhibitor Mechanisms (4 papers), Mesenchymal stem cell research (3 papers), Peptidase Inhibition and Analysis (2 papers), Liver physiology and pathology (2 papers), Tissue Engineering and Regenerative Medicine (2 papers), Pancreatic function and diabetes (2 papers) and Natural product bioactivities and synthesis (1 paper). The work is most often cited by research in Cancer Research (191 citations), Hepatology (91 citations), Genetics (115 citations), Immunology and Allergy (63 citations) and Molecular Biology (302 citations). Nataša Levičar has collaborated with scholars based in United Kingdom, Slovenia and Germany. Frequent co-authors include Tamara T. Lah, Janko Kos, Geoffrey J. Pilkington, Nagy Habib, Ricardo A. Dewey, Tadej Strojnik, M. Y. Gordon, Long R. Jiao, Timothy E. Bates and S. B. Marley. Their work appears in journals such as Cancer Gene Therapy, Acta Neurochirurgica, Cell Proliferation, Regenerative Medicine and Journal of Neuro-Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026